News
-
By Dr Ben Phillips, Dr Andrew Weeks and Professor Ary Hoffmann, School of Biosciences, University of Melbourne.
-
CSL’s Chief Executive Officer, Mr Paul Perreault, at the CSL Centenary Celebration Gala announcing the establishment of a new flagship $25 million fellowship program for early stage and translational research in Australia
-
Clarity’s strong collaboration with Associate Professor Paul Donnelly at the School of Chemistry and Bio21 Institute, University of Melbourne enabled the initial manufacture and development of the product that was then translated into the clinic in the recently completed SARTATE™ proof-of-concept clinical trial for neuroendocrine tumours (NETs).
-
Human red blood cells have remarkable abilities, allowing them to bend, extend and ‘squeeze’ through capillaries as they circulate through the blood stream.
-
Katherine Davies, Kimberley Callaghan, Wassif Kabir, Marycarol Holdaway and Gemma van Duijneveldt.
-
Dr Andrew Cuthbertson, CSL Chief Scientific Officer, The Governor of Victoria, The Honourable Linda Dessau, The Chancellor, Elizabeth Alexander AM, Dr Andrew Nash, Senior Vice President, Research, CSL Ltd.
-
Associate Professor Vincent Pettigrove, Dr Claudette Kellar and Mr Simon Sharp
By Daryl Holland
-
The Prime Minister, Hon. Malcolm Turnbull MP, made an announcement after touring the Bio21 Institute in Parkville on Monday March 10.
-
Paul Mulvaney, University of Melbourne
-
Image: Dr Ethan Goddard-Borger, Walter and Eliza Hall Institute and Professor Spencer Williams, School of Chemistry, Bio21 Institute, University of Melbourne Credit: Photography from the Walter and Eliza Hall Institute.